DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20181175

A comparative analysis of anxiolytic activity of Arnica montana and alprazolam in rats using open field test

Puja Jha, Seema Bhalerao, Mrunal Dhole

Abstract


Background: Anxiety affects around 7.3% of the total population worldwide. Benzodiazepines are preferred anxiolytic agents and are still frequently used in spite of the side effect profile including muscle relaxation, memory disturbances, sedation, physical dependence. Arnica montana, a traditional herb is known to possess significant anxiolytic effect at the dose of 100mg/kg. In this study, Arnica montana has been compared for the first time with alprazolam, a most commonly used anxiolytic drug.

Methods: Forced swim test was used to induce anxiety. Anxiolytic action of study drugs which were given orally, was evaluated using Open field test (OFT) in healthy wistar rats of either sex. Behavior of rats, locomotion and number of squares crossed was recorded. Rats were divided into four groups with eight rats in each group. Study groups were Group I Control; Group II Alprazolam 0.08mg/kg; Group III Arnica montana extract (AME) 100mg/kg; Group IV AME + Alprazolam group 100mg/kg+0.08mg/kg. Statistical analysis was done using ANOVA followed by Tukey’s test (p<0.05).

Results: Increase in frequency of rearing was significant (p<0.05) in AME group and highly significant (p<0.001) in Alprazolam and combination group in comparison to control. Decrease in frequency of grooming was highly significant (p<0.001) in Alprazolam and combination group. AME also showed significant (p<0.05) decrease in grooming activity.

Conclusions: Arnica montana extract showed anxiolytic activity and can be used as an add on drug after further studies and validation in the treatment of anxiety disorders.


Keywords


Anxiety, Alprazolam, Arnica montana, Grooming, Open field test, Rearing

Full Text:

PDF

References


Lango DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison”s principles of Internal Medicine. 18th Edi. Tata McGraw-Hill Company Mental disorder. 2012:352-9.

Baxter AJ, Scott KM, Vos T, Whiteford HA, Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013;43(5):897-910.

Holm M. Prescription of benzodiazepines in general practice in the country of Arhus, Denmark. Dan Med Bull. 1988;35(5):495-9.

Ahmed M, Saeed F, Mehajabeen, Jahan N. Neuro-Pharmacological and analgesic effects of Arnica Montana extract. Inter J Pharm Pharmacetic sci. 2013;5(4): 590-3.

Ballinger BR. New drugs, hypnotics and anxiolytics. BMJ. 1990;300(6722):456-8.

Beaubrun G, Gray GE. A review of herbal medicines for psychiatric disorders. Psychiatry. Serv. 2000;51(9):1130-4.

Lake J. Psychotropic medications from natural products: a review of promising research and recommendations. Altern. Ther Health Med. 2000;6(3):39-52.

Cryan JF, Sweeney FF. The age of anxiety: role of animal models of anxiolytic action in drug discovery. Br J Pharmacol. 2011;164:1129-61.

Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463(1-3):3-33.

Lister RG. Ethologically-based animal models of anxiety disorders. Pharmacol Ther. 1990;46:321-40.